These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3877407)

  • 1. [Intraepithelial lymphocytes (IEL) in murine ocular surface epithelium and effects of the topical application of OK-432 and interleukin-2].
    Tagawa Y; Takeuchi T; Saito M; Saga T; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1985 Jul; 89(7):832-7. PubMed ID: 3877407
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intra-tumoral injection therapy in patients with hepatocellular carcinoma].
    Watanabe S; Kagawa H; Shirai M; Nishioka M
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1635-41. PubMed ID: 3015038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined effect of the topical administration of OK-432 with radiation on the C3H mouse fibrosarcoma (NFSa)--TCD50 and the mechanism of action].
    Mukai M; Ando K; Koike S; Nagao K; Isono K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3432-5. PubMed ID: 3789754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistological studies of the skin at the injection site of cases receiving the streptococcal agent OK-432].
    Hanaue H; Kurosawa T; Miyakawa S; Horie F; Nemoto A; Yamoto H; Nishimura S; Tsuchiya H; Miura S; Asagoe T
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2271-8. PubMed ID: 3879494
    [No Abstract]   [Full Text] [Related]  

  • 6. [Local immunotherapy for cancer].
    Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of T-cell lymphoma with immunotherapy of OK-432--a case report (author's transl)].
    Nakayama S; Tsuji K; Kitajima K; Ueno K; Hoshino T
    Rinsho Ketsueki; 1980 Jan; 21(1):66-72. PubMed ID: 6966340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic studies on the effects of oral administration of streptococcal preparation OK-432. I. Effects of thoracic duct lymphocytes].
    Hanaue H; Kurosawa T; Nemoto A; Asagoe T; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1348-53. PubMed ID: 3501454
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y; Torisu M
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
    Nio Y; Ohgaki K; Kan N; Tsuchitani T; Imai S; Okino T; Hori T; Tobe T; Nakamura M; Kodama H
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2436-45. PubMed ID: 3449590
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in peripheral lymphocyte subsets before and after OK-432 administration in liver cancer].
    Yamamoto S; Omoto K; Yamamoto R; Ideguchi S; Oumi T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1077-8. PubMed ID: 3963851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of intratumoral administration of OK-432 on breast cancer--analysis of T cell subsets of tumor infiltrating lymphocytes by using the immunohistological stainings--preliminary report].
    Hosokawa T; Haga S; Shimizu T; Iida T; Imamura H; Watanabe O; Kajiwara T
    Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):316. PubMed ID: 2787471
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
    Komatsu K; Nakamura W
    C R Seances Soc Biol Fil; 1986; 180(1):117-20. PubMed ID: 2943364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
    Nio Y; Inamoto T; Hori T; Kan N; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):597-608. PubMed ID: 4056544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
    Fujimori M; Sugenoya A; Kobayashi S; Masuda H; Komatsu M; Takahashi S; Shimizu T; Tsuchiya S; Iida F
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2760-3. PubMed ID: 2551219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-lymphocyte mediated response in conjunctiva and cornea (an experimental study).
    Gogi R; Kulkarni PB; Nath K
    Indian J Ophthalmol; 1982 Jan; 30(1):29-35. PubMed ID: 6982853
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
    Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of large dose intratumoral administration of OK-432 in advanced cancer patients.
    Sakamoto J; Kondo T; Kamei H; Ichihashi H; Yamamura Y
    Nagoya J Med Sci; 1979 Dec; 42(1-2):27-36. PubMed ID: 530302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.